Inhibitors of c-fms kinase

Details for Australian Patent Application No. 2007240443 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Desjarlais, Renee Louise; Ballentine, Shelley K.; Wall, Mark; Chen, Jinsheng; Meegalla, Sanath K.; Wilson, Kenneth; Illig, Carl R.

Agent Shelston IP

Pub. Number AU-B-2007240443

PCT Pub. Number WO2007/124322

Priority 60/793,667 20.04.06 US

Filing date 18 April 2007

Wipo publication date 1 November 2007

Acceptance publication date 1 November 2012

International Classifications

C07D 233/90 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4172

A61K 31/437

A61K 31/5377

A61P 11/00 Drugs for disorders of the respiratory system

A61P 13/00 Drugs for disorders of the urinary system

A61P 35/00 Antineoplastic agents

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

Event Publications

13 November 2008 PCT application entered the National Phase

  PCT publication WO2007/124322 Priority application(s): WO2007/124322

1 November 2012 Application Accepted

  Published as AU-B-2007240443

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007240448-Methods and compositions for expressing negative-sense viral RNA in canine cells

2007240442-Inhibitors of c-fms kinase